Eli Lilly and Co seeks to intervene in the lawsuit between the USA Food and Drug Administration (FDA) and numerous pharmacists regarding whether there is still a supply shortage of Eli Lilly's weight-loss drug Tirzepatide. Eli Lilly claims that all of its medications have been available since August 2024. Eli Lilly believes that the USA FDA has other intentions in this lawsuit.
- Latest
- Detail
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
10:10
The UN Interim Force in Lebanon stated that the Israeli military intentionally destroyed its facilities.
09:48
The Credit Bond ETF Fund from China Asset Management is about to be issued, further enriching the on-site Bonds ETF product line.
09:39
Gold prices increased by about 27%, marking the largest annual increase in 14 years last year.
GS+0.90%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.